Dual-Targeting Therapy Offers New Hope Against Treatment-Resistant Metastatic Prostate Cancer
Executive Overview Prostate cancer remains one of the most prevalent and challenging malignancies facing male health worldwide. While localized cases boast high survival rates, the disease frequently claims lives once…
